The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunotherapy-Global Market Insights and Sales Trends 2024
Synopsis
The global Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunotherapy in various end use industries. The expanding demands from the Oncology, Inflammation, Central Nervous System and Others, are propelling Immunotherapy market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapeutic Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immunotherapy market, driven by demand from China, the second largest economy with some signs of stabilising, the Immunotherapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunotherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunotherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunotherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunotherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunotherapy covered in this report include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc.
The global Immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Global Immunotherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunotherapy market, Segment by Type:
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Global Immunotherapy market, by Application
Oncology
Inflammation
Central Nervous System
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunotherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunotherapy in various end use industries. The expanding demands from the Oncology, Inflammation, Central Nervous System and Others, are propelling Immunotherapy market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapeutic Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immunotherapy market, driven by demand from China, the second largest economy with some signs of stabilising, the Immunotherapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunotherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunotherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunotherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunotherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunotherapy covered in this report include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc.
The global Immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Global Immunotherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunotherapy market, Segment by Type:
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Global Immunotherapy market, by Application
Oncology
Inflammation
Central Nervous System
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunotherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immunotherapy
1.1 Immunotherapy Market Overview
1.1.1 Immunotherapy Product Scope
1.1.2 Immunotherapy Market Status and Outlook
1.2 Global Immunotherapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immunotherapy Market Size by Region (2018-2029)
1.4 Global Immunotherapy Historic Market Size by Region (2018-2023)
1.5 Global Immunotherapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immunotherapy Market Size (2018-2029)
1.6.1 North America Immunotherapy Market Size (2018-2029)
1.6.2 Europe Immunotherapy Market Size (2018-2029)
1.6.3 Asia-Pacific Immunotherapy Market Size (2018-2029)
1.6.4 Latin America Immunotherapy Market Size (2018-2029)
1.6.5 Middle East & Africa Immunotherapy Market Size (2018-2029)
2 Immunotherapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Therapeutic Vaccines
2.1.3 Checkpoint Inhibitors
2.1.4 Non-Specific Immunotherapy
2.2 Global Immunotherapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immunotherapy Historic Market Size by Type (2018-2023)
2.2.2 Global Immunotherapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immunotherapy Revenue Breakdown by Type (2018-2029)
3 Immunotherapy Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Inflammation
3.1.3 Central Nervous System
3.1.4 Others
3.2 Global Immunotherapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immunotherapy Historic Market Size by Application (2018-2023)
3.2.2 Global Immunotherapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immunotherapy Revenue Breakdown by Application (2018-2029)
4 Immunotherapy Competition Analysis by Players
4.1 Global Immunotherapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunotherapy as of 2022)
4.3 Date of Key Players Enter into Immunotherapy Market
4.4 Global Top Players Immunotherapy Headquarters and Area Served
4.5 Key Players Immunotherapy Product Solution and Service
4.6 Competitive Status
4.6.1 Immunotherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbvie
5.1.1 Abbvie Profile
5.1.2 Abbvie Main Business
5.1.3 Abbvie Immunotherapy Products, Services and Solutions
5.1.4 Abbvie Immunotherapy Revenue (US$ Million) & (2018-2023)
5.1.5 Abbvie Recent Developments
5.2 Amgen, Inc.
5.2.1 Amgen, Inc. Profile
5.2.2 Amgen, Inc. Main Business
5.2.3 Amgen, Inc. Immunotherapy Products, Services and Solutions
5.2.4 Amgen, Inc. Immunotherapy Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen, Inc. Recent Developments
5.3 Biogen
5.3.1 Biogen Profile
5.3.2 Biogen Main Business
5.3.3 Biogen Immunotherapy Products, Services and Solutions
5.3.4 Biogen Immunotherapy Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Immunotherapy Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Immunotherapy Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 Celgene
5.5.1 Celgene Profile
5.5.2 Celgene Main Business
5.5.3 Celgene Immunotherapy Products, Services and Solutions
5.5.4 Celgene Immunotherapy Revenue (US$ Million) & (2018-2023)
5.5.5 Celgene Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Immunotherapy Products, Services and Solutions
5.6.4 Johnson & Johnson Immunotherapy Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson & Johnson Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Immunotherapy Products, Services and Solutions
5.7.4 Merck Immunotherapy Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Immunotherapy Products, Services and Solutions
5.8.4 Novartis Immunotherapy Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Immunotherapy Products, Services and Solutions
5.9.4 Pfizer Immunotherapy Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 Roche
5.10.1 Roche Profile
5.10.2 Roche Main Business
5.10.3 Roche Immunotherapy Products, Services and Solutions
5.10.4 Roche Immunotherapy Revenue (US$ Million) & (2018-2023)
5.10.5 Roche Recent Developments
6 North America
6.1 North America Immunotherapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immunotherapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immunotherapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immunotherapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immunotherapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immunotherapy Market Dynamics
11.1 Immunotherapy Industry Trends
11.2 Immunotherapy Market Drivers
11.3 Immunotherapy Market Challenges
11.4 Immunotherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
